Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410603 · ClinicalTrials.gov registry record
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 64
- Enrollment target
NCT02410603: Completed study, sponsored by Mayo Clinic.
NCT02410603 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02410603 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells (PBMC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-12 |
| Est. Completion | 2021-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410603
The ClinicalTrials.gov registry entry for NCT02410603 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02410603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410603 about?
NCT02410603 is a clinical study titled "Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer". The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells (PBMC).
What is the current status of trial NCT02410603?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2016-12. Estimated completion is 2021-01-01.
Who is sponsoring clinical trial NCT02410603?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.